National Bureau of Economic Research

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, National Bureau of Economic Research sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials none currently recruiting 14 completed top decile by trial count

National Bureau of Economic Research: 14 sponsored US clinical trials, none currently recruiting.

National Bureau of Economic Research sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 14 completed. The most-studied condition in this pipeline is Coronavirus, with 1 trials.

Top-decile sponsor footprint

National Bureau of Economic Research ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

14 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

14 total, page 1 of 1

COMPLETED NA

Are Sugar-Sweetened Beverage Information Labels Well-Targeted

NCT05038163
COMPLETED NA

Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake

NCT05009251
COMPLETED NA

Lottery Incentive Nudges to Increase Influenza Vaccinations

NCT05012163
COMPLETED NA

COVID-19 Vaccination Take-Up

NCT04867174
COMPLETED NA

The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign

NCT04644328
COMPLETED NA

Covid-19 Messaging to Underserved Communities - 2nd Experiment

NCT04502056
COMPLETED NA

COVID-19 Health Messaging to Underserved Communities

NCT04371419
COMPLETED NA

Increasing Medication Adherence Through Physician Incentives and Messaging

NCT01603329
COMPLETED

The Effect of Proximity on Flu-Shot Participation

NCT01455753
COMPLETED NA

A Commitment Device for Medication Adherence Among HIV Patients

NCT01455740
COMPLETED NA

Understanding Medication Adherence Among HIV Patients

NCT01305590
COMPLETED NA

The Effect of Time-Slot Scheduling and Active Choice on Biometric Screening Participation

NCT01305798
COMPLETED NA

The Impact of Social Proximity on Conversion to Generic Prescription Medications

NCT01251419
COMPLETED NA

The Effect of Active Choice on Nurse Visit Participation

NCT01250392

Therapeutic Areas

Coronavirus 1
COVID-19 1

How the National Bureau of Economic Research archive is shaped

14 indexed studies, none listed as recruiting (0% open); 14 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Coronavirus (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

National Bureau of Economic Research: archived-pipeline peers nationwide

Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

National Bureau of Economic Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share National Bureau of Economic Research3-C Institute for Social DevelopmentAbbott Medical OpticsAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA10xBio22nd Century Group23andMe3 Waves Wellness
National Bureau of Economic Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

National Bureau of Economic Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this National Bureau of Economic Research page

14 registered trials is a research-attention snapshot, not an endorsement of National Bureau of Economic Research or any single study.

  • None of National Bureau of Economic Research's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Coronavirus is the condition National Bureau of Economic Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronavirus trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

National Bureau of Economic Research pipeline card: 14 registered trials from official public datasets.Report a data error.